David P. Recker

Matrix-Applied Characterized Autologous Cultured Chondrocytes Versus Microfracture: Five-Year Follow-up of a Prospective Randomized Trial

Mats Brittberg, David P. Recker, John Ilgenfritz et al. · The American Journal of Sports Medicine · 2018 · 271 citations

Tissue Engineering, Engineering, Bone Repair +22

A selective inhibitor of inducible nitric oxide synthase inhibits exhaled breath nitric oxide in healthy volunteers and asthmatics

Trevor T. Hansel, Sergei A. Kharitonov, Louise Donnelly et al. · The FASEB Journal · 2003 · 207 citations

Asthma, Inflammatory Lung Disease, Lung Inflammation +16

Ixmyelocel-T for patients with ischaemic heart failure: a prospective randomised double-blind trial

Amit N. Patel, Timothy D. Henry, Arshed A. Quyyumi et al. · The Lancet · 2016 · 168 citations

Thrombosis, Heart Failure, Transplantation +8

Valdecoxib, a COX-2???Specific Inhibitor, Is an Efficacious, Opioid-Sparing Analgesic in Patients Undergoing Hip Arthroplasty

Frédéric Camu, Tessa Beecher, David P. Recker et al. · American Journal of Therapeutics · 2002 · 141 citations

A Single Preoperative Oral Dose of Valdecoxib, a New Cyclooxygenase-2 Specific Inhibitor, Relieves Post-Oral Surgery or Bunionectomy Pain

Paul J. Desjardins, Vincent Shu, David P. Recker et al. · Anesthesiology · 2002 · 125 citations · Full text